JStar Capital Investments
Venture capitalActively deployingAustin · Seed–Late Stage · 13 people tracked
Also known as JSTAR FUND MANAGERS, LLC · JSTAR HORIZON GP II, LLC
Find your way into JStar Capital Investments
373 people in our graph share verified history with the JStar Capital Investments team — schools, employers, funds. One of them is your warm intro.
Investment thesis
JSTAR Capital Investments backs pioneering med-tech and healthcare companies whose breakthrough technologies and treatments can redefine medicine. Every investment is patient-centered, prioritizing solutions that deliver measurable improvements in health outcomes and address pressing global healthcare challenges. Focus areas include technologies that safeguard patients during complex cardiovascular procedures and reduce stroke/embolic risk, platforms modernizing healthcare delivery through imaging, surgical navigation, monitoring and workflow optimization, advancements improving implant performance and musculoskeletal restoration across trauma, spine and joint reconstruction, and breakthrough therapeutics and biologic delivery systems. The firm emphasizes sustainable, enduring value for investors and the broader healthcare ecosystem.
Source: firm website, verified Sep 15, 2026.
Team · 13 people
from the firm's website
What they invest in
from 8 of 8 portfolio companiesHealthtech ×7Medical Devices ×5Biotech ×4Digital Health ×3Hardware ×3SaaS ×3Enterprise Software ×1Fintech ×1
HQs:United States×6
Investments · 8 tracked
founders shown can be your intro pathAdhere+ is a Remote Therapeutic Monitoring (RTM) platform with an AARC framework that automates audit-ready documentation for regulatory compliance and provides physician-designed care protocols.
Digital HealthHealthtechSaaSWashington, US
Peter Pitts(Director)James Breidenstein(Executive Officer, Director)Dan Cohen(Executive Officer, Director)Scott Sigman MD(Director)John Stineman(Director)
Egg Medical develops the EggNest, a scatter radiation shielding system designed to reduce radiation exposure for interventional fluoroscopy teams during cardiac catheterization and endovascular procedures.
HardwareHealthtechMedical DevicesArden Hills, US
Robert F. Wilson(Founder & Chief Executive Officer)inJohn Gainor(Co-founder & Chief Technology Officer)inScott Youngstrom(Chief Financial Officer)inGavin Philipps(Chief Commercial Officer)in
BoardMarc Riviere(Director)Luc Marengere(Director)
Co-investorsTVM CapitalTVM Capital Life Science
Emblok develops the Emblok 360° whole body embolic protection system, a medical device used during left heart procedures such as TAVR to block and capture emboli and debris.
BiotechHardwareHealthtechMedical DevicesTampa, US
Bradley Brown(Executive Officer)inCharles Tribie(EVP, Manufacturing)
BoardAlan J. Simonian(Director)William M. Merhi(Director)
Osteocentric develops orthopedic implant systems for bone fixation, including fasteners, plates, and surgical instruments that use UnifiMI mechanical integration technology.
BiotechHardwareHealthtechMedical DevicesAustin, US
FundPanel is fund administration software that helps venture capital back-office teams manage investor communications and produce reporting.
Enterprise SoftwareFintechSaaS
Co-investorsAirTree VenturesAmboy Street VenturesBIOSPRING PARTNERSBonfire VenturesCollide CapitalCongruent Ventures+13 more
Significo develops digital health products and custom technology solutions for insurers and large employers, as well as licensable SaaS offerings like a personalized health recommendation engine and apps for chronic condition management and employee wellness.
Digital HealthHealthtechInsurTechSaaSWellness & Fitness
Sonavex develops medical device technologies focused on vascular access and related clinical applications, drawing on ultrasound-based imaging and monitoring products.
BiotechDigital HealthHealthtechMedical DevicesBaltimore, US
David Narrow(Executive Officer, Director)inDevin O'Brien-Coon(Co-Founder & Chairman)inJerry L. Prince(Co-Founder)inJohn Rappe(Executive Officer)inAlex Yevzlin(Executive Officer)
BoardRobert Hallenbeck(Director)
Co-investorsFusionKeiretsu ForumMaryland TEDCORembrandt Venture PartnersRiptide VenturesTEDCO+2 more
Zetagen is a biotechnology company focused on bone-related disease, developing small-molecule therapeutics and approaches targeting bone tumor progression, stem cell activity to promote bone formation, and cancers such as Ewing's sarcoma.
BiotechHealthtechMedical DevicesSyracuse, US
Joe C Loy(Executive Officer, Director)Peter B. Finn(Executive Officer)Nikhil Thakur, MD(Executive Officer, Director)David Tischler(Executive Officer, Director)
BoardRichard Warburg(Director)Ashok Kaveeshwar(Director)
Portfolio news
latest coverage across their companiesSonavex · intelligence360.news · Aug 10, 2026
Emblok · intelligence360.news · Jul 20, 2026
Egg Medical · intelligence360.news · Jul 20, 2026
Zetagen · finsmes.com · Nov 26, 2025
Frequently asked questions
- How many investments has JStar Capital Investments made?
- JStar Capital Investments has 8 tracked investments, including 2 dated in the last 24 months.
- What stage does JStar Capital Investments invest at?
- JStar Capital Investments invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does JStar Capital Investments focus on?
- JStar Capital Investments focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is JStar Capital Investments located?
- JStar Capital Investments is headquartered in Austin, US.
- Who does JStar Capital Investments co-invest with?
- JStar Capital Investments most often shares deals with AirTree Ventures, Congruent Ventures, igniteXL Venture, among 27 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
T. Rowe Price is a global asset management firm that actively invests across markets to pursue opportunities on behalf of its clients.
New Alliance Capital is a Shanghai-based private equity and venture capital firm founded in 2008, focused on technology-driven sectors. Its backers include state-owned enterprise groups, insurance capital, fund-of-funds, government guidance funds, and listed companies.
Bay City Capital is a venture capital firm founded in 1997 that has raised five venture funds totaling $1.3 billion in capital commitments and invested in more than 100 companies worldwide.